News & Press Releases

ESG Co-chair Jacob Hupart spoke to E&E News providing insight on the new SEC rule aimed at improving transparency in corporate climate reporting and how it will impact the comparability of data across different firms.

CNBC spoke with Member Theresa Carnegie on the legal battle over Medicare drug price negotiations. Drug makers argue that such negotiations would force them to sell medicine at significant discounts, violating their due process under the Fifth Amendment. Theresa commented on the government’s initial victories and their potential impact on remaining legal challenges.

Health Law Chair and Health Care Enforcement Defense Co-chair Karen Lovitch spoke with Laboratory Economics offering insight on two recent cases where the former owner of a Missouri healthcare company, Genotec DX, and clinical laboratory, Advanced Geriatric Management LLC (AGM), and a compliance officer face prison time over fraudulent claims. The former owner admitted to submitting more than $3.8 million in false claims to Medicare, Medicaid, and private healthcare benefit programs.

Private Equity Co-Chair Matthew T. Simpson spoke with Private Equity International on trends in private equity and the potential implications for mid-market private equity sponsors.

Northeastern Law Magazine profiled Member and alum Drew DeVoogd, detailing his journey from bartender to patent and trade secret litigator and trial attorney, catalyzed by his transformative co-op experience at the US Attorney’s Office.

Member Kevin Amendt recently shared his perspective on the shifting landscape in high-tech intellectual property as clients adopt a more strategic approach to licensing. Read the full article here in Managing IP.